A

Alphamab Oncology

Sustainability Report and Carbon Intensity Rankings

Is Alphamab Oncology doing their part?

Their DitchCarbon score is 32

Alphamab Oncology has a DitchCarbon Score of 32 out of 100, indicating a lower performance in sustainability measures. This score suggests that the company has a relatively high carbon intensity compared to more sustainable peers. Efforts to reduce emissions and improve sustainability practices are needed to increase their score.

This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.

Industry emissions intensity

Very low

Low

Medium

High

Very high

Alphamab Oncology is part of the health and social services industry, which has a low carbon intensity ranking compared to other industries. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.

Location emissions intensity

Very low

Low

Unknown

High

Very high

Alphamab Oncology is situated in China, a region with a carbon intensity rating that influences the company’s environmental impact. The sustainability efforts of the company are affected by China’s national strategies and policies on carbon emissions.

Unlock 30+ emissions intelligence data points

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

Unlock 30+ emissions data points on Alphamab Oncology

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

9.56%

...this company is doing 9.56% worse in emissions than the industry average.

Alphamab Oncology, founded in 2015, is a biopharmaceutical company based in China that specializes in the research, development, production, and commercialization of innovative oncology drugs. The company made its debut on the Hong Kong Stock Exchange on December 12, 2019, under the stock code 9966. Operating within the health and social services industry, Alphamab Oncology is dedicated to advancing cancer treatment options.

Compare Alphamab Oncology with other companies in the same industry –>

emission intelligence's platform recommendations for Alphamab Oncology

Alphamab Oncology should undertake a thorough inventory of all Scope 1 emissions sources and pursue energy efficiency improvements throughout its operations, while also shifting to low-carbon or renewable energy sources to potentially reduce emissions by 15%.

Bad news, Alphamab Oncology hasn't committed to SBTi goals yet.

Alphamab Oncology has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company is still in the process of defining its goals for reducing greenhouse gas emissions in line with climate science.

Not participating

Claim this profile

Are you associate with this company?
Help us improve our data and claim this profile.

Our methodology

Read about our emission calculation methodologies, and what the DitchCarbon Score means.

Other company reports in this industry

Looking for a specific company?

Search our company directory or contact us for custom data requests.

A

Alphamab Oncology

Sustainability Report and Carbon Intensity Rankings

Is Alphamab Oncology doing their part?

Their DitchCarbon score is 32

Industry emissions intensity

Very low

Low

Medium

High

Very high

Location emissions intensity

Very low

Low

Unknown

High

Very high

Unlock 30+ emissions intelligence data points

Unlock 30+ emissions data points on Alphamab Oncology

...this company is doing 9.56% worse in emissions than the industry average.

emission intelligence's platform recommendations for Alphamab Oncology

Bad news, Alphamab Oncology hasn't committed to SBTi goals yet.

Claim this profile

Our methodology

Other company reports in this industry

Looking for a specific company?

Quicklinks

Resources

Get in touch